Syneron Medical (Syneron Medical) Change In Working Capital : $-7.3 Mil (TTM As of Mar. 2017)

View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Change In Working Capital?

Syneron Medical's change in working capital for the quarter that ended in Mar. 2017 was $-5.6 Mil.

Syneron Medical's change in working capital for the fiscal year that ended in Dec. 2016 was $-12.3 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Syneron Medical Change In Working Capital Historical Data

The historical data trend for Syneron Medical's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Change In Working Capital Chart

Syneron Medical Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Change In Working Capital

Get a 7-Day Free Trial

-13.91

-31.60

4.99

-15.41

-12.35

Syneron Medical Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Change In Working Capital	Get a 7-Day Free Trial															-10.72	1.17	0.42	-3.22	-5.64

Syneron Medical Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.3 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Syneron Medical Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneron Medical (Syneron Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.syneron.com

Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.

Executives

North Tide Capital, Llc	10 percent owner	500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan	director, 10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp	10 percent owner	C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines

From GuruFocus

Why Is Seth Klarman Loading Up on Syneron Medical?

By matsandalex matsandalex • 08-29-2011

Top Seth Klarman Holding, ELOS Rockets Up 20%

By matsandalex matsandalex • 02-17-2011

Seth Klarman More Than Doubles Holdings in Syneron Medical

By teddycx teddycx • 07-12-2011

Seth Klarman Buys First American Corp., Universal Compression Holdings, School Specialty Inc., Sells Courtside Acquisition Corp, Healthsouth Corp.

By gurufocus • 08-13-2007